Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P, Borgfeldt C, Holmberg E, Staf C, Falconer H, Bjurberg M, Kjölhede P, Rosenberg P, Stålberg K, Högberg T, Åvall-Lundqvist E. Dahm-Kähler P, et al. Among authors: kjolhede p. Gynecol Oncol. 2017 Jan;144(1):167-173. doi: 10.1016/j.ygyno.2016.10.039. Epub 2016 Nov 3. Gynecol Oncol. 2017. PMID: 27817932
Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
Stålberg K, Kjølhede P, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Falconer H, Holmberg E, Staf C, Tholander B, Åvall-Lundqvist E, Rosenberg P, Högberg T. Stålberg K, et al. Among authors: kjolhede p. Int J Cancer. 2017 Jun 15;140(12):2693-2700. doi: 10.1002/ijc.30707. Epub 2017 Apr 12. Int J Cancer. 2017. PMID: 28340503 Free article.
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.
Hjerpe E, Staf C, Dahm-Kähler P, Stålberg K, Bjurberg M, Holmberg E, Borgfeldt C, Tholander B, Hellman K, Kjølhede P, Högberg T, Rosenberg P, Åvall-Lundqvist E. Hjerpe E, et al. Among authors: kjolhede p. Acta Oncol. 2018 Mar;57(3):331-337. doi: 10.1080/0284186X.2017.1400691. Epub 2017 Nov 12. Acta Oncol. 2018. PMID: 29130381
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E, Holmberg E, Kjølhede P, Marcickiewicz J, Rosenberg P, Tholander B, Åvall-Lundqvist E, Högberg T. Stålberg K, et al. Among authors: kjolhede p. Acta Oncol. 2019 Nov;58(11):1628-1633. doi: 10.1080/0284186X.2019.1643036. Epub 2019 Aug 2. Acta Oncol. 2019. PMID: 31373248
Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
Bjurberg M, Holmberg E, Borgfeldt C, Flöter-Rådestad A, Dahm-Kähler P, Hjerpe E, Högberg T, Kjølhede P, Marcickiewicz J, Rosenberg P, Stålberg K, Tholander B, Hellman K, Åvall-Lundqvist E. Bjurberg M, et al. Among authors: kjolhede p. Gynecol Oncol. 2019 Nov;155(2):229-236. doi: 10.1016/j.ygyno.2019.08.022. Epub 2019 Aug 30. Gynecol Oncol. 2019. PMID: 31477283
103 results